-
Product Insights
NewClot Management Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Clot Management Devices Pipeline Market Report Overview Clot Management Devices are used for the removal or dissolution of a clot from a blood vessel to restore proper blood circulation. This device is used as a routine procedure while performing percutaneous coronary intervention and for treating potentially life-threatening complications. The clot management devices pipeline market research report provides comprehensive information on the products with their comparative segment-wise analysis in various stages of development. The report also covers the regional and country-wise...
-
Product Insights
Hip Reconstruction Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Hip Reconstruction Pipeline Market Overview Hip reconstruction or hip replacement is a procedure that involves the replacement of the damaged or diseased parts of the hip joint. This category includes devices (implants) used in hip replacement procedures. The hip reconstruction pipeline market research report provides comprehensive information about the hip reconstruction pipeline reconstruction with a comparative analysis of the reconstruction at various stages of development and information about the clinical trials which are in progress. Key Segments ·      Primary Hip...
-
Product Insights
ReWalk Robotics Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our ReWalk Robotics Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. ReWalk Robotics Ltd (ReWalk) is a medical device company that designs, develops and commercializes exoskeletons. The company offers walk restoration devices for people with lower limb disabilities to stand and walk once again. Its products include ReWalk personal system and ReWalk rehabilitation. ReWalk’s Rewalk personal system is a battery-powered system that controls movement using subtle changes in the center...
-
Product Insights
NewMedRhythms Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our MedRhythms Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. MedRhythms Inc (MedRhythms) is a digital therapeutics company that uses sensors, music, and software to build neurologic interventions, evidence-based, to measure and improve walking. MedRhythms is headquartered in Boston, Massachusetts, the US. GlobalData's Medical Devices company profile report, “MedRhythms Inc Pipeline Insight and Competitive Landscape, 2023" provides information about the company overview and analysis on their pipeline products. This company...
-
Product Insights
Stroke Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Stroke can occur with symptoms including sudden numbness in their face or limbs, particularly down one side of their body. The sufferer may appear confused and have trouble talking or understanding what is being said to them. They may have vision problems, and trouble walking or keeping their balance. The Stroke pipeline drugs market research report outlays comprehensive information on the Stroke targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA)...
-
Product Insights
Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C – Drugs In Development, 2022, provides an overview of the Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C (Genetic Disorders) pipeline landscape. Niemann-Pick C disease is one of a group of lysosomal storage diseases that affect metabolism and that are caused by genetic mutations. It involves the accumulation of sphingolipids in cells throughout the body, particularly reticuloendothelial cells (the mononuclear phagocyte system). Symptoms include...
-
Sector Analysis
Parkinson’s Disease – Epidemiology Forecast to 2029
Parkinson's disease (PD) is a progressive disorder of the nervous system that affects movement by causing shaking, stiffness, and difficulty with walking, balance, and coordination (National Institute on Aging, 2017; Mayo Clinic, 2020). PD is associated with motor symptoms involving bradykinesia, rest tremor, rigidity, and postural disturbances, as well as non-motor symptoms including hyposmia, rapid eye movements, sleep behavior disorder, and depression (World Health Organization, 2020). PD is the second most common chronic progressive neurodegenerative disorder in the elderly after...
-
Product Insights
Orthopedic Braces and Supports – Medical Devices Pipeline Assessment, 2020
Orthopedic braces and supports are external devices that provide support to and immobilize joints and weakened musculoskeletal groups. Braces and supports ensure that the affected body part is held in the correct position to facilitate function and healing. GlobalData's Medical Devices sector report, “Orthopedic Braces and Supports-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Orthopedic Braces and Supports pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which...
-
Sector Analysis
Amyotrophic Lateral Sclerosis – Epidemiology Forecast to 2029
Amyotrophic lateral sclerosis (ALS) is a group of rare but fatal neurodegenerative diseases that primarily involve the nerve cells (neurons) in the brain and spinal cord responsible for controlling voluntary muscle movement like chewing, walking, and talking (National Institute of Neurological Disorders and Stroke, 2020). ALS is often called Lou Gehrig's disease, after the baseball player who was diagnosed with the disease in 1939 (Mayo Clinic, 2019). Most people with ALS die from respiratory failure, usually within three to five...